A detailed history of Tfc Financial Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Tfc Financial Management holds 4,371 shares of ABBV stock, worth $845,875. This represents 0.13% of its overall portfolio holdings.

Number of Shares
4,371
Previous 4,437 1.49%
Holding current value
$845,875
Previous $807,000 7.19%
% of portfolio
0.13%
Previous 0.14%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$154.79 - $180.76 $10,216 - $11,930
-66 Reduced 1.49%
4,371 $749,000
Q1 2024

Apr 30, 2024

BUY
$159.82 - $182.1 $1,438 - $1,638
9 Added 0.2%
4,437 $807,000
Q4 2023

Jan 25, 2024

SELL
$137.6 - $154.97 $27,932 - $31,458
-203 Reduced 4.38%
4,428 $686,000
Q3 2023

Oct 23, 2023

BUY
$133.59 - $154.65 $2,404 - $2,783
18 Added 0.39%
4,631 $690,000
Q2 2023

Aug 07, 2023

SELL
$132.51 - $164.9 $27,827 - $34,629
-210 Reduced 4.35%
4,613 $621,000
Q1 2023

May 08, 2023

BUY
$144.61 - $166.54 $37,453 - $43,133
259 Added 5.67%
4,823 $768,000
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $691 - $829
5 Added 0.11%
4,564 $738,000
Q2 2022

Aug 03, 2022

BUY
$137.62 - $174.96 $1,651 - $2,099
12 Added 0.26%
4,559 $698,000
Q1 2022

May 04, 2022

BUY
$131.98 - $163.75 $1,055 - $1,310
8 Added 0.18%
4,547 $737,000
Q3 2021

Nov 02, 2021

BUY
$106.4 - $120.78 $279,832 - $317,651
2,630 Added 137.77%
4,539 $490,000
Q2 2021

Jul 29, 2021

SELL
$105.21 - $117.21 $6,838 - $7,618
-65 Reduced 3.29%
1,909 $215,000
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $169,586 - $199,038
1,974 New
1,974 $173,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $342B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Tfc Financial Management Portfolio

Follow Tfc Financial Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tfc Financial Management, based on Form 13F filings with the SEC.

News

Stay updated on Tfc Financial Management with notifications on news.